BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 Conference

Stock Information for BiondVax Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.